Digirad received the European CE Mark of approval for its Cardius X-ACT solid state SPECT imager. It features low dose volume CT attenuation correction, 3D-OSEM reconstruction and upright imaging capability.
The company already has approval from the FDA to market the Cardius X-ACT in the U.S.
Press release: Digirad Receives CE Mark Approval for Advanced, Solid-State Cardius(R) X-ACT Imaging System